Congress Asset Management’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-152,829
Closed -$13.3M – 383
2022
Q3
$13.3M Buy
152,829
+18,998
+14% +$2M 0.14% 121
2022
Q2
$15.2M Buy
133,831
+29,316
+28% +$3.36M 0.15% 110
2022
Q1
$13.5M Buy
104,515
+24,804
+31% +$3.57M 0.12% 135
2021
Q4
$14.4M Buy
79,711
+11,258
+16% +$1.95M 0.11% 122
2021
Q3
$10.2M Buy
68,453
+3,108
+5% +$476K 0.08% 156
2021
Q2
$9.9M Buy
65,345
+5,275
+9% +$734K 0.08% 148
2021
Q1
$7.8M Buy
60,070
+4,891
+9% +$627K 0.07% 161
2020
Q4
$6.62M Buy
+55,179
New +$5.41M 0.06% 158

Other funds holding OMCL

Congress Asset Management's OMCL Position: Q4 2022 in Review

Congress Asset Management sold out of Omnicell (OMCL) in Q4 2022, closing a stake of 152,829 shares — an estimated $13.3M sold.

Congress Asset Management first reported a position in OMCL in Q4 2020 and held it in 8 quarters. The position peaked at $15.2M in Q2 2022. 328 funds tracked by Wall St. Rank hold OMCL as of Q4 2022.

  • Congress Asset Management reported no remaining Omnicell position as of Q4 2022 after selling out during the quarter.
  • Congress Asset Management sold 152,829 Omnicell shares in Q4 2022, an estimated $13.3M.
  • Congress Asset Management first reported a position in Omnicell in Q4 2020 and held it in 8 quarters.
  • Congress Asset Management's Omnicell position peaked at $15.2M in Q2 2022.
  • 328 funds tracked by Wall St. Rank held Omnicell as of Q4 2022.

Based on Congress Asset Management's 13F filing for Q4 2022, filed 18 Jan 2023.